Lifeline Biotechnologies (LLBO) Stock Statistics & Valuation Metrics

Lifeline Biotechnologies has a market cap or net worth of $3.04M. The enterprise value is $10.37M.

Lifeline Biotechnologies has 4,348,921,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lifeline Biotechnologies’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -11.35%.

The current PE Ratio of Lifeline Biotechnologies is ―. Lifeline Biotechnologies’s PEG ratio is 2.03.

In the last 12 months, Lifeline Biotechnologies had revenue of 0.00 and earned -43.39K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Lifeline Biotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―

Lifeline Biotechnologies upcoming earnings date is ―, ―.

Lifeline Biotechnologies as a current ratio of 0.46, with Debt / Equity ratio of ―

In the past 12 months, Lifeline Biotechnologies has paid 0.00 in taxes.

Lifeline Biotechnologies EV to EBITDA ratio is -239.02, with an EV/FCF ratio of 74.17.

Lifeline Biotechnologies has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Lifeline Biotechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―